Characteristics and functions of murine cutaneous dendritic cells: A synopsis of recent developments

Mucosal Immunology

Volumn 1, Issue 6, 2008, Pages 470-474

  Udey, M C ^a   Nagao, K ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; LANGERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA1;

ACCESSORY CELL; ANTIGEN EXPRESSION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL SUBPOPULATION; CELL TYPE; CYTOLOGY; DENDRITIC CELL; GENETIC ENGINEERING; GRAFT REJECTION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CELL; SKIN GRAFT;

EID: 54349086638     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2008.37     Document Type: Review

References (32)

1. Kissenpfenning, A. & Malissen, B. Langerhans cells - revisiting the paradigm using genetically engineered mice. Trends Immunol. 27 132-139 (2006).
2. Shortman, K. & Naik, S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30 (2007).
3. Merad, M., Ginhoux, F. & Collin, M. Origin, homeostasis and function of human and mouse langerin+ dendritic cells. Nat. Rev. Immunol. (in press).
4. Katz, S.I., Tamaki, K. & Sachs, D.H. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282, 324-326 (1979).
5. Frelinger, J.G., Hood, L., Hill, S. & Frelinger, J.A. Mouse epidermal Ia molecules have a bone marrow origin. Nature 282, 321-323 (1979).
6. Schuler, G. & Steinman, R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526-546 (1985).
7. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-52 (1998).
8. Steinman, R.M. & Nussenzweig, M.C. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99, 351-358 (2002).
9. Kissenpfenning, A. et al. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol. Cell. Biol. 25, 88-99 (2005).
10. Kaplan, D.H. et al. Epidermal Langerhans cell-defi cient mice develop enhanced contact hypersensitivity. Immunity 23, 611-620 (2005).
11. Kissenpfenning, A. et al. Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 643-654 (2005).
12. Bennett, C.L. et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell. Biol. 169, 569-576 (2005).
13. Ginhoux, F. et al. Blood-derived dermal langerin dendritic cells survey the skin in the steady state. J. Exp. Med. 204, 3133-3146 (2007).
14. Bursch, L.S. et al. Identifi cation of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204, 3147-3156 (2007).
15. Poulin, L.F. et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204, 3119-3131 (2007).
16. Borkowski, T.A., Nelson, A.J., Farr, A.G. & Udey, M.C. Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur. J. Immunol. 26, 110-114 (1996).
17. Merad, M. et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135-1141 (2002).
18. Merad, M. et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10, 510-517 (2004).
19. Borkowski, T.A., Letterio, J.J., Farr, A.G. & Udey, M.C.A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184, 2417-2422 (1996).
20. Borkowski, T.A. et al. A role for TGFbeta1 in Langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J. Clin. Invest. 100, 575-581 (1997).
21. Kaplan, D.H et al. Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204, 2545-2552 (2007).
22. Bogunovic, M. et al. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J. Exp. Med. 203, 2627-2638 (2006).
23. Ginhoux, F. et al. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7, 265-273 (2006).
24. Larregina, A.T. et al. Dermal-resident CD14+ cells differeniate into Langerhans cells. Nat. Immunol. 2, 1151-1158 (2001).
25. Cheong, C. et al. Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. J. Immunol. Methods 324, 48-62 (2007).
26. Strid, J. et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat. Immunol. 9, 146-154 (2008).
27. Obhrai, J.S. et al. Langerhans cells are not required for efficient skin graft rejection. J. Invest. Dermatol. 128, 1950-1955 (2008).
28. Stoecklinger, A. et al. Epidermal Langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J. Immunol. 179, 886-893 (2007).
29. Bennett, C.L. et al. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J. Immunol. 179, 6830-6835 (2007).
30. Stoitzner, P. et al. Tumor immunotherapy by epicutaneous immunization requires Langerhans cells. J. Immunol. 180, 1991-1998 (2008).
31. Wang, L. et al. Langerin expressing cells promote skin immune responses under defined conditions. J. Immunol. 180, 4722-4727 (2008).
32. Bennett, C.L. & Clausen, B.E. DC ablation in mice: Promises, pitfalls, and challenges. Trends Immunol. 28, 525-531 (2007).